These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21727766)

  • 1. Arsenic trioxide plus cisplatin/interferon α-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma.
    Tomuleasa C; Soritau O; Fischer-Fodor E; Pop T; Susman S; Mosteanu O; Petrushev B; Aldea M; Acalovschi M; Irimie A; Kacso G
    Hematol Oncol Stem Cell Ther; 2011; 4(2):60-6. PubMed ID: 21727766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.
    Tomuleasa C; Soritau O; Rus-Ciuca D; Pop T; Todea D; Mosteanu O; Pintea B; Foris V; Susman S; Kacsó G; Irimie A
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):61-7. PubMed ID: 20361077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
    Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
    Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model.
    Zhang KZ; Zhang QB; Zhang QB; Sun HC; Ao JY; Chai ZT; Zhu XD; Lu L; Zhang YY; Bu Y; Kong LQ; Tang ZY
    J Hematol Oncol; 2014 Mar; 7():28. PubMed ID: 24678763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells.
    Tomuleasa C; Soritau O; Orza A; Dudea M; Petrushev B; Mosteanu O; Susman S; Florea A; Pall E; Aldea M; Kacso G; Cristea V; Berindan-Neagoe I; Irimie A
    J Gastrointestin Liver Dis; 2012 Jun; 21(2):187-96. PubMed ID: 22720309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma.
    Wang W; Qin SK; Chen BA; Chen HY
    World J Gastroenterol; 2001 Oct; 7(5):702-5. PubMed ID: 11819858
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.
    Rangwala F; Williams KP; Smith GR; Thomas Z; Allensworth JL; Lyerly HK; Diehl AM; Morse MA; Devi GR
    BMC Cancer; 2012 Sep; 12():402. PubMed ID: 22963400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
    Zheng T; Yin D; Lu Z; Wang J; Li Y; Chen X; Liang Y; Song X; Qi S; Sun B; Xie C; Meng X; Pan S; Liu J; Jiang H; Liu L
    Mol Cancer; 2014 May; 13():133. PubMed ID: 24884809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin plus PIAF combination chemotherapy for hepatocellular carcinoma.
    Petrushev B; Tomuleasa C; Soritau O; Aldea M; Pop T; Susman S; Kacso G; Berindan I; Irimie A; Cristea V
    Exp Oncol; 2012; 34(1):17-24. PubMed ID: 22453143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.
    Jia Q; Zhang X; Deng T; Gao J
    Cell Reprogram; 2013 Apr; 15(2):143-50. PubMed ID: 23438193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells.
    Meng XZ; Zheng TS; Chen X; Wang JB; Zhang WH; Pan SH; Jiang HC; Liu LX
    J Gastroenterol Hepatol; 2011 Jan; 26(1):186-93. PubMed ID: 21175813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans retinoic acid and arsenic trioxide induce apoptosis and modulate intracellular concentrations of calcium in hepatocellular carcinoma cells.
    Wei J; Ye C; Liu F; Wang W
    J Chemother; 2014 Dec; 26(6):348-52. PubMed ID: 25068185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
    Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect and mechanism of arsenic trioxide on hepatocellular carcinoma].
    Liu LX; Zhu AL; Chen W; Guo HX; Wang XQ; Liu ZH; Zhang TD; Jiang HC; Wu M
    Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(1):33-6. PubMed ID: 15774171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial Effect of Arsenic and Herbal Compounds in Telomerase-Mediated Apoptosis Induction in Liver Cancer.
    Chaudhary A; Bhardwaj SK; Khan A; Srivastava A; Sinha KK; Ali M; Haque R
    Biol Trace Elem Res; 2023 Jul; 201(7):3300-3310. PubMed ID: 36192614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periostin contributes to arsenic trioxide resistance in hepatocellular carcinoma cells under hypoxia.
    Liu Y; Gao F; Song W
    Biomed Pharmacother; 2017 Apr; 88():342-348. PubMed ID: 28119236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells.
    Chen X; Zhang M; Liu LX
    Oncol Rep; 2009 Jul; 22(1):73-80. PubMed ID: 19513507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment.
    Gatti L; Cossa G; Tinelli S; Carenini N; Arrighetti N; Pennati M; Cominetti D; De Cesare M; Zunino F; Zaffaroni N; Perego P
    J Pharmacol Exp Ther; 2014 Mar; 348(3):360-71. PubMed ID: 24345465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of arsenic trioxide on human hepatocellular carcinoma HepG2 cells: inhibition of proliferation and induction of apoptosis.
    Siu KP; Chan JY; Fung KP
    Life Sci; 2002 Jun; 71(3):275-85. PubMed ID: 12034346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
    Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.